Léonardo Scapozza

9.4k total citations · 1 hit paper
187 papers, 7.4k citations indexed

About

Léonardo Scapozza is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Léonardo Scapozza has authored 187 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 43 papers in Epidemiology and 28 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Léonardo Scapozza's work include Monoclonal and Polyclonal Antibodies Research (26 papers), Herpesvirus Infections and Treatments (21 papers) and Toxin Mechanisms and Immunotoxins (15 papers). Léonardo Scapozza is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (26 papers), Herpesvirus Infections and Treatments (21 papers) and Toxin Mechanisms and Immunotoxins (15 papers). Léonardo Scapozza collaborates with scholars based in Switzerland, Italy and Germany. Léonardo Scapozza's co-authors include Remo Perozzo, Gerd Folkers, Hans‐Uwe Simon, Shída Yousefi, Inès Schmid, Andrew Ziemiecki, Thomas Schaffner, Thomas Brunner, Carlo Gambacorti‐Passerini and Rocco Piazza and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Léonardo Scapozza

182 papers receiving 7.2k citations

Hit Papers

Calpain-mediated cleavage of Atg5 switches autophagy to a... 2006 2026 2012 2019 2006 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis
    2006 1.1k citations Léonardo Scapozza et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Léonardo Scapozza Switzerland 43 3.6k 1.5k 874 821 811 187 7.4k
Jianping Ding China 49 7.8k 2.2× 1.1k 0.7× 612 0.7× 430 0.5× 698 0.9× 187 11.8k
David W. Banner Switzerland 45 4.2k 1.2× 769 0.5× 738 0.8× 2.2k 2.6× 1.1k 1.3× 103 9.1k
A. D’Arcy Switzerland 41 4.0k 1.1× 470 0.3× 932 1.1× 619 0.8× 832 1.0× 61 7.0k
Guillaume Lessène Australia 34 5.1k 1.4× 714 0.5× 1.2k 1.4× 608 0.7× 1.7k 2.1× 78 7.3k
Keiryn L. Bennett Austria 45 5.8k 1.6× 738 0.5× 1.1k 1.3× 384 0.5× 2.2k 2.8× 120 9.5k
Peter E. Czabotar Australia 47 8.9k 2.5× 1.2k 0.8× 2.1k 2.4× 621 0.8× 2.2k 2.7× 98 11.8k
W. Douglas Fairlie Australia 45 5.6k 1.6× 727 0.5× 1.3k 1.5× 543 0.7× 2.4k 2.9× 103 8.7k
Dirk B. Mendel United States 43 4.2k 1.2× 2.2k 1.5× 1.3k 1.5× 772 0.9× 770 0.9× 74 8.0k
John R. Engen United States 53 7.8k 2.2× 452 0.3× 1.4k 1.6× 586 0.7× 791 1.0× 194 11.3k
Yung‐Chi Cheng United States 54 5.5k 1.5× 2.0k 1.4× 1.6k 1.8× 1.2k 1.5× 725 0.9× 272 10.4k

Countries citing papers authored by Léonardo Scapozza

Since Specialization
Citations

This map shows the geographic impact of Léonardo Scapozza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léonardo Scapozza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léonardo Scapozza more than expected).

Fields of papers citing papers by Léonardo Scapozza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Léonardo Scapozza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léonardo Scapozza. The network helps show where Léonardo Scapozza may publish in the future.

Co-authorship network of co-authors of Léonardo Scapozza

This figure shows the co-authorship network connecting the top 25 collaborators of Léonardo Scapozza. A scholar is included among the top collaborators of Léonardo Scapozza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Léonardo Scapozza. Léonardo Scapozza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smedt, Thibaut De, et al.. (2025). Discovery of the First Efficacious Adenosine 2A Receptor Negative Allosteric Modulators for High Adenosine Cancer Immunotherapies. Journal of Medicinal Chemistry. 68(4). 4059–4078. 3 indexed citations
2.
3.
4.
Culot, Maxime, et al.. (2023). Challenges and Opportunities in the Oral Delivery of Recombinant Biologics. Pharmaceutics. 15(5). 1415–1415. 8 indexed citations
5.
Braun, Simon M. G., et al.. (2023). Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog pathway inhibitor-1. Nature Communications. 14(1). 3893–3893. 6 indexed citations
6.
Mologni, Luca, Sébastien Tardy, Alfonso Zambon, et al.. (2022). Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase. ACS Omega. 7(20). 17083–17097. 10 indexed citations
7.
Cavalli, Andrea, Jacopo Sgrignani, Jonathan P. Sleeman, et al.. (2022). CEMIP (HYBID, KIAA1199): structure, function and expression in health and disease. FEBS Journal. 290(16). 3946–3962. 20 indexed citations
8.
9.
Moll, Solange, Andrea Angeletti, Léonardo Scapozza, et al.. (2021). Glomerular Macrophages in Human Auto- and Allo-Immune Nephritis. Cells. 10(3). 603–603. 10 indexed citations
10.
Scapozza, Léonardo, et al.. (2020). How ‘Protein-Docking’ Translates into the New Emerging Field of Docking Small Molecules to Nucleic Acids?. Molecules. 25(12). 2749–2749. 24 indexed citations
11.
Neff, L., Hesham M. Ismail, Marta Sierra, et al.. (2018). Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy. Nature Communications. 9(1). 4848–4848. 26 indexed citations
12.
Mukherjee, Budhaditya, Juha Vahokoski, Inari Kursula, et al.. (2018). Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases. The EMBO Journal. 37(7). 10 indexed citations
13.
Žagar, Andreja Vujičić, Léonardo Scapozza, & Oscar Vadas. (2017). Design and purification of active truncated phosphoinositide 3-kinase gamma protein constructs for structural studies. Protein Expression and Purification. 135. 1–7. 3 indexed citations
14.
Mologni, Luca, Carlo Gambacorti‐Passerini, Peter G. Goekjian, & Léonardo Scapozza. (2016). RET kinase inhibitors: a review of recent patents (2012–2015). Expert Opinion on Therapeutic Patents. 27(1). 91–99. 17 indexed citations
15.
Tardy, Sébastien, Alexandre Orsato, Luca Mologni, et al.. (2014). Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors. Bioorganic & Medicinal Chemistry. 22(4). 1303–1312. 22 indexed citations
16.
Wang, Tai, William H. Bisson, Pascal Mäser, Léonardo Scapozza, & Didier Picard. (2014). Differences in Conformational Dynamics between Plasmodium falciparum and Human Hsp90 Orthologues Enable the Structure-Based Discovery of Pathogen-Selective Inhibitors. Journal of Medicinal Chemistry. 57(6). 2524–2535. 39 indexed citations
17.
18.
Ceccon, Monica, Luca Mologni, William H. Bisson, Léonardo Scapozza, & Carlo Gambacorti‐Passerini. (2012). Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors. Molecular Cancer Research. 11(2). 122–132. 71 indexed citations
19.
Novaković, Ivana, Tatjana Gazivoda Kraljević, Sandra Kraljević Pavelić, et al.. (2011). A new N-methyl thymine derivative comprising a dihydroxyisobutenyl unit as ligand for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK). Bioorganic & Medicinal Chemistry Letters. 21(20). 6161–6165. 6 indexed citations
20.
Scapozza, Léonardo, Didier Rognan, Gerd Folkers, & Angelika Daser. (1995). Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein. Acta Crystallographica Section D Biological Crystallography. 51(4). 541–549. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianping Ding Breakdown of academic impact, for papers by David W. Banner Breakdown of academic impact, for papers by A. D’Arcy Breakdown of academic impact, for papers by Guillaume Lessène Breakdown of academic impact, for papers by Keiryn L. Bennett Breakdown of academic impact, for papers by Peter E. Czabotar Breakdown of academic impact, for papers by W. Douglas Fairlie Breakdown of academic impact, for papers by Dirk B. Mendel Breakdown of academic impact, for papers by John R. Engen Breakdown of academic impact, for papers by Yung‐Chi Cheng
Rankless by CCL
2026